To establish a market size and forecast for molecular point of care systems, it’s necessary to understand what it is that is being measured. If a market for every dollar earned by selling any system that “could be used” in molecular point of care was established, the market would be much larger and have much […]

Per Kalorama Information’s World Infectious Disease report: Opportunities for infectious disease testing products vary widely between the developed and developing countries, according to our most recent report on infectious disease world markets. With favorable access to a complete range of tests and the operation of advanced medical delivery systems that reach most residents and in spite of making […]

The IVD market follows patients where technologies allow. There’s no greater evidence for need for IVD product makers to find a market in physician office labs than the declining hospital bed count. With declining hospital bed in developed countries and slow growth in hospital bed volume even in developing nations, it makes sense that more […]